FDA Initiatives To Expedite Reviews Pay Off In FY’11 Approvals
A report released on the 35 innovative drug approvals in the fiscal year touts the role of many FDA initiatives in speeding and streamlining drug development and approval.
A report released on the 35 innovative drug approvals in the fiscal year touts the role of many FDA initiatives in speeding and streamlining drug development and approval.